INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

SNSEFaeth Therapeutics, Inc.

CIK 0001829802

EDGAR filingsOpen in network
Disclosed transactions36
Buys / sells17 / 0
Max Insider Score49
Connections8with evidence

SNSE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Gift
G—
100.0K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Schayowitz AdamDirector · Oct 27, 2026
  • ← Insider ofevidence
    Vousden Karen HDirector · Sep 15, 2026
  • ← Insider ofevidence
    Stephenson Brian CChief Financial Officer · Jun 24, 2026
12
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Gift
G
—
100.0K sh
Oct 30, 2026
Nov 3, 2026
traded Oct 30, 2026
+4d
SEC FORM 4

Evidence

9
SA
Schayowitz AdamDirector
FTHFaeth Therapeutics, Inc.
Grant or award
A—
25.0K sh
Oct 23, 2026Oct 27, 2026
traded Oct 23, 2026
+4dSEC FORM 4

Evidence

9
VH
Vousden Karen HDirector
FTHFaeth Therapeutics, Inc.
Grant or award
A—
25.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$105K
4,212 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,777
100 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,639
100 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$92K
3,400 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$73K
2,891 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$78K
3,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$35K
1,358 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$14K
580 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M$9,527
8,213 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

21
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M—
45.3K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$23K
1,118 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$36K
1,797 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$35K
1,583 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

49
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$77K
3,329 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$8,526
356 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

45
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$165K
6,836 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$49K
1,969 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

30
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$11K
425 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

37
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$55K
2,806 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

16
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M$52K
45.3K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Option exercise
M—
8,213 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
45 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
761.4K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Grant or award
A—
25.0K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC FORM 4

Evidence

9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
44.8K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
761 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

9
GC
Gerry ChristopherPresident & PEO
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
220.0K sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC FORM 4

Evidence

9
CJ
Craver JosiahPFO & PAO
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
80.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
809.8K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
56.7K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
1.24M sh
Feb 19, 2026Feb 19, 2026
traded Feb 19, 2026
+0dSEC FORM 4

Evidence

9
PK
Parikh Anand KiranDirector, Chief Operating Officer
SNSEFaeth Therapeutics, Inc.
Grant or award
A—
92.5K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

← Insider ofevidence
Hahn Stephen M.
Director · Jun 16, 2026
  • ← Insider ofevidence
    Gerry ChristopherPresident & PEO · Jun 12, 2026
  • ← Insider ofevidence
    Craver JosiahPFO & PAO · Apr 14, 2026
  • ← Insider ofevidence
    Parikh Anand KiranDirector, Chief Operating Officer · Feb 19, 2026
    • Source error

    Price history for SNSE is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.